Csontritkulás: ki dolgozik rajta

Intézményenként egy kártya. Válassz célpontot, és csak az azon dolgozó csoportok maradnak.

• Minden célpont
• RANKL 1
• PI3K 0
• NRF2 0
• AKT 0
• CTNNB1 0
• MAPK 0
• SIRT1 0
• mTOR 0
• AMPK 0
• PPAR 0
• STAT3 0
• ERK 0
• NLRP3 0
• YAP 0
• GPX4 0
• GLP-1 1
• TP53 0
• STING 0
• TNF 0
• HIF-1 0
• JAK 0
• METTL3 0
• IL-6 0
• PTEN 0
• VEGF 0
• CXCR4 0
• JNK 0
• MMP-9 0
• ESR1 0
• IL-4 0
• MEK 0
• PINK1 0
• SGLT2 0
• APP 0
• COX-2 0
• CSF1R 0
• DPP-4 0
• FTO 0
• HMGB1 0
• IL-1 0
• KIT 1
• APOE 0
• CD40 0
• CGRP 0
• EGFR 0
• EZH2 0
• FOXP3 0
• MYC 0
• TFEB 0
• ACE2 0
• AXL 0
• BRAF 0
• BRCA1 0
• BRCA2 0
• BRD4 0
• CCR5 0
• CDK4/6 0
• FGFR 0
• G6PD 0
• HSP90 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-ERC

  Extending Female Reproductive Longevity: Neurovascular Control of the Ovarian Reserve (dOvary)

  Academisch Ziekenhuis Leiden· Leiden, Hollandia· EU contribution 2 500 000 EUR· until 2031. okt.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Predicting Effective Plant Phosphopeptide–Calcium Formulations Using Machine Learning for Ca/Vitamin D3 and K2 Supplement Development via Pickering Emulsion (CaVita-Phos)

  Christian-Albrechts-Universitaet Zu Kiel· Kiel, Németország· EU contribution 202 125 EUR· until 2028. szept.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  A Human Muscle-Bone Organoid-on-Chip to Study Bone Mechano- Adaptation via Optogenetic Control (BONE-TUNE)

  Eidgenoessische Technische Hochschule Zuerich· Zuerich, Svájc· EU contribution 292 119 EUR· until 2028. jún.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Hypothalamic cell changes during menopause: the neuroendocrine origin of its metabolic alterations (HypoPause)

  Universidad de Santiago de Compostela· Santiago De Compostela, Spanyolország· EU contribution 1 498 325 EUR· until 2031. jan.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  EVOLUTIONARY MECHANISMS OF AGE-RELATED BONE LOSS ACROSS THE HUMAN AND HOMINID SKELETON (STAND UP)

  Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev· Munchen, Németország· EU contribution 401 232 EUR· until 2028. dec.· 3 countries

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Development of Rietveld tomography to measure Local Anisotropic Strain and its Application to Bone Nanostructures (RIETOM)

  Aarhus Universitet· Aarhus C, Dánia· EU contribution 247 553 EUR· until 2027. dec.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Using electromechanical stimulations on bone remodeling to speed-up repair bone damage (BONEREPAIR)

  Universite de Lorraine· Nancy Cedex, Franciaország· EU contribution 2 574 732 EUR· until 2030. nov.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Molecular chirality tools for the study of Gluten Immunogenic Peptides and Celiac Disease: Novel therapeutic and diagnostic approaches. (GLUCHIRAL)

  Universidad de Sevilla· Sevilla, Spanyolország· EU contribution 226 441 EUR· until 2028. febr.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Multiparametric Evaluation of osteosarcopeniA diSease Using magnetic Resonance ImagiNG (MEASURING)

  Alma Mater Studiorum - Universita di Bologna· Bologna, Olaszország· EU contribution 172 750 EUR· until 2027. aug.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-RIA

  Integrated care digital-based interventions for multimorbid patients suffering from chronic respiratory conditions in Brazil, Serbia and Türkiye (MULTIPULM)

  Uni Systems Systimata Pliroforikis Monoprosopi Anonymi Emporiki Etairia· Athina, Görögország· EU contribution 4 399 688 EUR· until 2029. júl.· 10 countries

  The disease is named only in the funder's project summary, not in the title.

10 of 26 running projects, newest first. Listed amounts together: 61,7 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 17
• Organoids 1
• Mendelian Randomization Analysis 90
• CRISPR-Cas Systems 1
• Gene Expression Profiling 60
• Sequence Analysis, RNA 5
• Whole Genome Sequencing 1
• Exome Sequencing 6
• Proteomics 23
• Metabolomics 25
• Mass Spectrometry 7
• Flow Cytometry 6
• Immunohistochemistry 10
• Xenograft Model Antitumor Assays 3
• Magnetic Resonance Imaging 73
• Machine Learning 79
• Deep Learning 38
• Cohort Studies 236
• Genome-Wide Association Study 83

• Vitamin D3 Treatment Alters Thyroid Functional Morphology in Orchidectomized Rat Model of Osteoporosis.

  Int J Mol Sci, 2022. jan.

• Melatonin is a potential drug for the prevention of bone loss during space flight.

  J Pineal Res, 2019. júl.

• Central role of the proximal tubular αKlotho/FGF receptor complex in FGF23-regulated phosphate and vitamin D metabolism.

  Sci Rep, 2018. máj.

• The effect of simvastatin treatment on bone repair of femoral fracture in animal model.

  Growth Factors, 2015. márc.

• Does coenzyme-Q have a protective effect against atorvastatin induced myopathy? A histopathological and immunohistochemical study in albino rats.

  Histol Histopathol, 2014. nov.

• Effect of implantation of biodegradable magnesium alloy on BMP-2 expression in bone of ovariectomized osteoporosis rats.

  Mater Sci Eng C Mater Biol Appl, 2013. máj.

• Curcumin inhibits inflammatory response and bone loss during experimental periodontitis in rats.

  Acta Odontol Scand, 2012. máj.

• Simvastatin induces estrogen receptor-alpha expression in bone, restores bone loss, and decreases ERα expression and uterine wet weight in ovariectomized rats.

  J Bone Miner Metab, 2010. nov.

• Mandibular bone alterations of ovariectomized rats under vitamin D insufficiency.

  Histol Histopathol, 2008. ápr.

• Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor-alpha.

  J Nutr, 2004. jan.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.